While alpha-fetoprotein is a commonly used clinical diagnostic and prognostic predictive marker for HCC, we discovered a negative correlation between alpha-fetoprotein levels and TRIP13 protein levels. This evidence concerns the gene TRIP13 and hepatocellular carcinoma.